Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03619382 · ClinicalTrials.gov registry record
An Evaluation Of Healthy Ankle Motion And Morphology
A clinical trial, sponsored by Paragon 28.
- Completed
- Registry status
- 19
- Enrollment target
NCT03619382: Completed study, sponsored by Paragon 28.
NCT03619382 is a clinical trial that has completed, run by Paragon 28. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03619382 has completed, sponsored by Paragon 28.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Determine motion and morphology of the healthy ankle during simulated gait.
Primary Outcome
Determine relative tri-axial rotations between bones of the foot and ankle using reconstructed 3-dimensional computer models. All rotations will be measured in degrees (°).
Interventions
- RADIATION Cone Beam Computed Tomography
- RADIATION Radiographs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2020-12-31 |
What the finished NCT03619382 record still lists
NCT03619382 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Cone Beam Computed Tomography is the first listed.
NCT03619382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03619382 about?
NCT03619382 is a clinical study titled "An Evaluation Of Healthy Ankle Motion And Morphology". Determine motion and morphology of the healthy ankle during simulated gait.
What is the current status of trial NCT03619382?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2018-07-16. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03619382?
The interventions under investigation include: Cone Beam Computed Tomography (RADIATION), Radiographs (RADIATION).
Who is sponsoring clinical trial NCT03619382?
This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI